SLC5A2 and diabetes mellitus: We also showed that SGLT2 inhibition decreases renal lipid accumulation and inflammation and prevents the development of nephropathy in db/db mice regardless whether they have insulin-deficient diabetes or insulin-resistant diabetes [31].